IRCT20220919055992N2已完成1 期
Safety and Feasibility Study of Using Hemoperfusion with HA380 Filter to Improve Heart and Liver Transplant Outcomes: Phase I Clinical Trial
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •eligible for organ donation
- •have consent and aware of donation
排除标准
- •liver cirrhosis
- •heart failure
- •prior heart surgery
研究者
相似试验
已完成
2 期
Hemoperfusion in patients with COVID-19IRCT20150704023055N2Babol University of Medical Sciences10
进行中（未招募）
不适用
A pilot study on the safety and efficacy of haemopoietic stem cell mobilization (CD34+ cells) with MOZOBIL ± G-CSF, in adult patients diagnosed with beta-thalassaemia major.Beta-thalassaemia majorMedDRA version: 12.0Level: LLTClassification code 10004505Term: Beta thalassaemiaMedDRA version: 12.0Level: LLTClassification code 10004514Term: Beta-thalassaemiaMedDRA version: 12.0Level: LLTClassification code 10043391Term: Thalassaemia betaEUCTR2009-014136-37-GRniversity of Washington
已完成
不适用
Clinical research for hemoperfusion therapy with an immobilized polymyxin B (PMX) fiber column in patients with severe influenza pneumonia in Vietnam and Japasevere influenza pneumoniaJPRN-UMIN000003669Disease Control and Prevention Center10
招募中
不适用
Hemoperfusion effect in treatment of patients with COVID-19IRCT20110425006280N12Vice President of Research Guilan university of medical sciences20
已完成
不适用
Investigation of the effect of direct hemoperfusion with polymyxin B-immobilized fiber on steroid resistant drug-induced lung injury.JPRN-UMIN000017263Graduate School of Medicine, Osaka City University20